Integrative analysis reveals CRHBP inhibits renal cell carcinoma progression by regulating inflammation and apoptosis

Patients with renal cell carcinoma (RCC) usually develop drug resistance and have poor prognosis owing to its insensitive property. However, the underlying mechanisms of RCC are still unclear. We implemented an integrative analysis of The Cancer Genome Atlas and Gene Expression Omnibus datasets. Thr...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Kang, Xiao, Yusha, Xu, Tao, Yu, Weimin, Ruan, Yuan, Luo, Pengcheng, Cheng, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group US 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445881/
https://www.ncbi.nlm.nih.gov/pubmed/31570754
http://dx.doi.org/10.1038/s41417-019-0138-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7445881/
https://www.ncbi.nlm.nih.gov/pubmed/31570754
http://dx.doi.org/10.1038/s41417-019-0138-2

Ejemplares similares